As the prevalence of diabetes approaches 10% in the United States and with an annual cost of over $240 billion, improving the quality of diabetes care through meaningful uses of technology is a national health priority. 5 We are now entering an exciting time in diabetes management as electronic health record (EHR) innovations open up new possibilities for the use of health IT in the primary care of patients with type 2 diabetes. Understanding the successes and unintended consequences of EHRs on the quality of diabetes care can help identify tools and strategies that health care organizations can leverage to improve patient outcomes. In this article, we review a selection of informative studies that demonstrate the impact of EHRs on the quality of diabetes care to date and that illustrate future directions for how EHRs might improve the care of patients with diabetes.
Introduction
For this narrative review, we selected leading articles published over the past decade that examined the clinical impact of EHRs on diabetes care. This review is organized into the following sections: (1) impact of the initial adoption of basic EHRs (including care reminders and registries), (2) newer innovative health IT tools that leverage an underlying EHR infrastructure (eg, secure messaging, online coaching, patient portals), and (3) potential next steps and future avenues of health IT use on quality of diabetes care. Rather than a formal evidence-based summary of the literature, our goal is to provide a conceptual framework for how EHRs-and innovations leveraging EHRs-can be adapted to improve the outpatient care of patients with type 2 diabetes. The reader is referred elsewhere for reviews of technology focused on blood glucose monitoring, 6 in-patient diabetes care, 7 or artificial pancreas. 8 Research articles were drawn primarily from the English language literature and were evaluated by the authors with regard to quality, timeliness, and relevance. Studies with rigorous methodology were preferred, with randomized controlled trials (RCTs, n = 9), large prospective cohort studies (n = 8), and systematic reviews (n = 3) having highest priority.
improved clinical biomarkers, and reduced cost of care. 9, 10 This effect is thought to stem from enhanced coordination between health care providers and the ability of EHRs to promote the adoption of organizational guidelines for clinical diabetes care. 10 However, the "real world" experience of new EHR systems often falls short of published results when the implementation is not well coordinated or does not sufficiently involve key stakeholders (eg, the clinicians who must use the new tools).
Two validated EHR-enabled tools that have facilitated these early benefits are diabetes registries and clinical decision support systems.
Diabetes Registries
EHRs provide a structured, comprehensive, and longitudinal patient data set that can be used to continuously track and monitor clinical outcomes on a large scale. 11 As medical practices and health systems become more adept at using EHRs, they can extract and summarize clinical data such as diagnosis codes, pharmacy medication records, and laboratory test results from individual patient records to measure overall quality of care and set clinical benchmarks. 12 These data can then be used to identify specific subpopulations of patients that may require additional organizational resources to improve care.
In the Diabetes Mellitus: Putting Evidence into Practice randomized trial, registry patients with outlying clinical biomarkers and overdue follow-up were identified by a population manager, reminder letters were sent to patients to obtain testing, and primary care providers (PCPs) received standardized messages alerting them to patients who were out of range. This intervention resulted in increased adherence to laboratory testing schedules but did not have a significant impact on glycemic control. 13 Conversely, in a study among patients with poor baseline glycemic control, investigators were able to achieve a small but significant increase in the proportion of patients at target for glycemic control (6.4% increase vs 3.8% increase in control group, P < .001) when patients and practitioners were supplied with quarterly diabetes management report cards generated from a patient registry. 14 This inconsistent effect of registries between studies suggests that while improving the organization of information using registries may have some early benefits, systems that already achieve relatively good diabetes control need tools that can help translate the information from registries into clinical action.
Clinical benefits are more likely to be seen when diabetes registries are used to enhanced patient-provider interactions. In an RCT by Stroebel and colleagues, 15 for example, significant reductions in HbA1c, LDL cholesterol, and blood pressure were achieved using data generated from a patient registry to engage patients using a customized health promotion letter. As a population management tool, registries can also improve the coordination of care and follow-up of patients with diabetes, especially those who are in the poorest control and those who have the greatest probability of complications. 12 Though registry-based interventions alone do not always have a significant clinical impact, this population-based approach to care represents a significant advance in care delivery compared to traditional office-based individual patient management.
Clinical Decision Support
Clinical guidelines for optimal management of diabetes are widely available, yet adherence to these guidelines remains variable. 16 Clinical decision support (CDS) systems are designed to guide optimal medical therapy based on individual patient characteristics derived from the EHR. 17 In contrast to registries, CDS can be provided at the point of care when the clinician is with the patient. CDS tools have been developed to provide reminders for routine lab testing, recommendations for specific medication choices, and alerts for potential drug-drug interactions. In an early RCT by Sequist et al, 18 electronic clinical reminders were shown to increase adherence to recommended pharmacotherapy and screening (odds ratio [OR] 1.30, 95% confidence interval [CI] 1.01-1.67), though no clinical outcomes regarding the actual effectiveness of diabetes care were reported. Furthermore, this study indicated that only a minority of clinicians acted on the clinical reminders (less than one-third), implying attenuated CDS efficacy in the face of individual clinician workflows. 18 This is a critically important finding, since poorly implemented and designed tools that do not take provider work flow and clinical needs into account inevitably fail to deliver their full promise of more evidence-based care. Ultimately, while CDS may have some marginal benefits in diabetes care, a knowledge gap by the clinician is rarely the primary reason for patients not reaching goals of glycemic control.
The COMPETE II study by Holbrook et al 19 showed that when decision support was shared by the clinician and the patient through a web-based interface, significant improvements in clinical diabetes care can be achieved. Using a composite outcome of testing and risk factor control based on American Diabetes Association guidelines, patients in this study achieved significant benefit (difference in composite score of 1.27, 95% confidence interval [CI] 0.79-1.75, P < .001). These findings underscore a promising application of CDS: creating tools to elicit the patient's input may lead to more effective management changes. This study involved a relatively small cohort of patients, and though the potential of shared CDS systems was observed, incorporating patient input is still difficult despite the increasing digital connectivity of patients. O'Connor et al 20 conducted an RCT that sought to improve the impact of CDS by increasing the specificity of the clinical prompts and creating a clinical workflow, which required providers to acknowledge the CDS prompts before they could close their visit encounter. This study found modestly improved glycemic control (HbA1c: intervention effect -0.26%, CI 95%: -0.06 to -0.47; P = .01) and better maintenance of systolic blood pressure control (80.2% vs 75.1%, P = .03), though no improvement in LDL levels were achieved. There exists a fine balance between prompting clinicians to follow guidelines, incorporating patient input, and achieving positive clinical change with CDS systems without misfiring through inability to adapt simple rules to complex patients. One strength of CDS systems is that, when well implemented, these systems lead to higher system-level reliability by requiring explicit definitions of recommended clinical care choices. Overall these CDS systems marginally improve clinical outcomes in diabetes management but are highly dependent on implementation. 21
Leveraging Advanced EHRs for Innovative Diabetes Care
The organized clinical information in EHRs provides a rich platform on which more advanced functionality can be constructed. One of the primary innovations of more advanced EHRs is the direct engagement of patients with their clinical care data.
Personal Health Records
Recent applications of advanced EHRs have focused on using clinical EHR data in conjunction with the patiententered information to individualize diabetes care. For example, the EHR can be used to generate interactive content for patients-a personalized health record (PHR)-that can be displayed online and on mobile devices. In more advanced systems, the patient-facing user interfaces of PHRs can be used as 2-way communication channels between the clinician and patient. In an early RCT of this model, patients in the intervention group were given access to a web-based PHR to set goals and develop a "Diabetes Care Plan" prior to their clinical encounter. 22 This intervention was shown to result in a statistically significant increase in medication changes for intervention patients at their next visit (53% vs 15% of visits with medication changes among control patients; P < .001). This study represents one of the earliest examples of a PHR reducing patient barriers to medication intensification. A significant limitation of this study, however, was that only a small minority of the overall diabetes population had registered for online portal access, and the patients that had registered tended to have be younger and have better baseline HbA1c. As familiarity and comfort with online activities increases nationwide, including among older patients and those from disadvantaged backgrounds, these PHR-based tools will become increasingly generalizable. Indeed, work by investigators at Group Health, an integrated care system, has found high rates of use by patients with diabetes over age 65. 23 A key insight from this line of research is that one of the most important benefits of advanced patient portal tools is the ability to facilitate visitindependent communication between providers and patients.
EHR-Supported Self-Management
In addition to supporting population-level and visit-based care, the data in EHRs can be used to develop personalized web-based self-management support systems. 24 For example, the recently published Engaging and Motivating Patients Online With Enhanced Resources-Diabetes (EMPOWER-D) study examined the impact of a PHR on clinical interactions and online self-management tools. 25 Various data elements of clinical diabetes care including glucometer readings, dietary intake, and physical activity were digitally tracked and collated into a readily interpretable "Diabetes Status Report." The data in this report were used to engage both a nurse care manager and dietician as well as provide audiovisual content directly to the patients in the intervention group. Significant reductions in HbA1c at 6 months (Intervention: -1.31% vs Usual Care: -0.66%, P < .001) were observed, though the difference at 12 months between groups was not significant. This study developed and validated a novel paradigm of primary health care delivery: Data were generated by the patient and gathered digitally, contextualized with patient input and applied to clinical analysis and decision making. It also demonstrated that diabetes can be effectively managed in a continuous manner with an ongoing dialogue between the patient and a non-MD health care provider through a PHR populated with patient generated health data. A recent Cochrane systematic review confirmed that computer-based diabetes selfmanagement interventions to manage type 2 diabetes appear to have a small beneficial effect on blood glucose control, with an effect that was larger in studies using mobile phones. 26 
Secure Electronic Messages
Care systems with integrated EHRs also have the potential to support secure electronic messaging between patients and their care team. Electronic communication can save time for the patient, address concerns outside the visit, and be used as a tool to maintain more frequent contacts. In a longitudinal analysis of secure messaging among 6301 adults with diabetes within the Group Health system, for example, investigators found that recent and frequent messaging use was associated with better glycemic control and a higher rate of HbA1c testing adherence, suggesting that secure messaging may facilitate important processes of care and help some patients to achieve or maintain adequate glycemic control. 27 These results were also seen in an analysis of 35 423 people with diabetes and/or hypertension by Zhou et al, 28 that found the use of secure patient-physician email within a 2-month period was associated with an improvement of 2.0-6.5 percentage points in performance on HEDIS measures such as glycemic (HbA1c), cholesterol, and blood pressure screening and control. However, another analysis of a secure messaging implementation found that the increased access provided by secure messaging may have been associated with increased subsequent clinical utilization. 29 One possible explanation for this discrepancy may be that newly implemented secure messaging capability uncovers a previously unmet demand for services that are now more easily accessed. While this may lead to a short-term increased utilization, the hope is that over the long run this will result in a new equilibrium with better overall care.
Peer Navigators
A clear limitation of advanced EHR innovations designed to include patients more directly in their care is that many patients have limited access to, or limited facility with, using such online tools. However, there have been advances in this area as well, such as the development of peer-based teaching using web-based tools, use of clinical personnel trained to help patients use online tools (so-called "electronic navigators" or e-navigators), and even virtual coaches. 30, 31 One innovative interweaving of technology with outreach is the ongoing iDecide/Decido study, which uses tailored online diabetes medication decision aids to enable community health workers to provide personalized patient education to underserved Latino and African American adults. 32 Another promising area is the creation of virtual online communities in which patients selfidentify and share information, build community, and provide each other with support around living with diabetes. 33
Unintended Adverse Consequences and Next Steps
Given the high level of complexity and integration required of EHRs and their rapid development and implementation across large patient populations, there remains significant untapped potential in how EHRs are currently used. EHRs are able to generate and store extensive clinical data, which is a strength but also presents challenges for how to most effectively organize and present data for both care team members and patients. PCPs, who are currently the largest source of data input into the EHR, are often overburdened by basic patient data entry and administrative documentation for billing purposes. 34 Advances in EHR applications must account for physician workflow, address real (rather than presumed) needs, and must present information in a way that reduces the number of screen changes and clicks that each clinician must perform to gather relevant data. Unintended adverse consequences of increased EHR use that have been identified include increased work for clinicians, inefficient new workflows, altered communication practices that are less effective, and overdependence on technology. 35 Historically, many new EHR applications have been developed with insufficient provider and patient input. Increased attention to key stakeholders using user-centered design principles is needed to ensure more effective uptake of innovative tools. 36 Moreover, usability for diverse patient populations such as those with limited health literacy is virtually nonexistent. Keeping these concerns in mind when developing and implementing new tools will be critical to supporting more effective dissemination of EHR innovations.
As EHR adoption increases both in breadth of practices and depth of functionality, there are several potential areas for growth. Efficient approaches to integrating patient collected exercise and dietary data into the clinical record may help with lifestyle self-management. Increased tailoring of therapy, management, and self-management will be possible, although data standards for health care sensors, wireless health trackers, and patient generated health data must be established so that data can be assimilated across various platforms. Clinical data such as costs, appointment information, or emergency care that are often isolated in "silos" must be made accessible across providers and across care systems to improve integration of electronically stored clinical information.
Summary
This is an exciting time in diabetes care. Increasingly evidence-based management guidelines are providing a strong clinical base for care, care systems are becoming more integrated, and we are well into the "next generation" of health IT tools designed to support diabetes care. Advances in technology are opening up new alternatives to traditional visitbased management. Further research is now needed to develop, implement, and rigorously evaluate these new health IT-supported care models. Moreover, these new technologies should be implemented in a way that reduces disparities in diabetes care by being accessible and useable by all patients, including Spanish-speaking, low-literacy, and other vulnerable populations who have the greatest need and most to gain from improved diabetes care.
